Download full report with analyst certification and important disclosures
Mar 4 2026, 08:09 GMT
Symrise
FY25 results modestly ahead; 2026 guide in line but slow start expected
DAVY VIEW
Strong margin delivery, supported by cost savings, resulted in a 2% EBITDA beat for Symrise in 2025. Cash metrics were healthy. 2026 guidance is along expected lines, reflecting challenging market conditions; the guide includes a low-single-digit organic sales decline for Q1-26, which is more negative than our model and implies a significant acceleration for H2-26.
